Quick Takeaways
- BAILLIE GIFFORD & CO filed SCHEDULE 13G/A for Moderna, Inc. Common Stock (MRNA).
- Disclosed ownership: 6.5%.
- Date of event: 31 Mar 2025.
BAILLIE GIFFORD & CO - 31 Mar 2025 SCHEDULE 13G/A Report for Moderna, Inc. Common Stock (MRNA)
- Filing Manager
- BAILLIE GIFFORD & CO
- Reporting Manager
- BAILLIE GIFFORD & CO
- Security
- Moderna, Inc. Common Stock
- Symbol
- MRNA
- Shares outstanding
- 383,823,969 shares
- Disclosed Ownership
- 24,948,558 shares
- Ownership
- 6.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Apr 2025, 06:47:36 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 12 Feb 2025
- Next filing
- 09 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"BAILLIE GIFFORD & CO disclosed 6.5% ownership in Moderna, Inc. Common Stock (MRNA) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 12 Feb 2025.
- Current filing was accepted on 30 Apr 2025, 06:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO | 6.5% | 24,948,558 | 23,662,282 | 0 | Grant Meikle | Threshold and Transaction Reporting Manager |